
US equities markets engineered a major comeback after being hammered at the opening bell. The SPY ETF, which tracks the S&P 500, was down over 2% before reversing to become positive by the latter part of the session. The healthcare ETF XLV and the biotech ETF IBB both bounced back as well and were positive at the time this content was recorded. Meanwhile, Imprimis Pharmaceuticals (IMMY) rallied strongly due to an upgrade from Lake Street with a $10 price target. Here’s a recap.